Clinical outcomes and complications in Latarjet versus free bone block procedures for anterior shoulder instability: a meta-analysis of comparative studies
European Journal of Orthopaedic Surgery & Traumatology · 2025
DOI: 10.1007/s00590-025-04485-0 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, 2025. Verfasst von Aleksander Sulkowski und 4 weiteren Autor:innen. Beteiligte Einrichtung: King's College London, London, UK. aleksander.sulkowski@kcl.ac.uk. Hauptthemen laut MEDLINE: Joint Instability, Shoulder Joint, Shoulder Dislocation, Bone Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The Latarjet procedure is thought to reduce recurrence by creating a dynamic restraint against instability, known as the “sling effect”. Conversely, free bone block (FBB) techniques provide stability through bony augmentation alone, without relying on the sling effect. This study compares the clinical outcomes of the Latarjet procedure and FBB techniques in adult patients to determine whether the sling effect offers a significant advantage in reducing recurrence rates.
Methods
A systematic search of PubMed, Embase, and MEDLINE databases was conducted on 03/03/2025. Only comparative studies that included data on recurrence rate, patient-reported outcome measures (PROMs), range of motion, or reoperation rates were selected for analysis. We assessed the risk of bias using RoB 2 and ROBINS-I tools and performed a meta-analysis. PROSPERO ID: CRD42024517955.
Results
Ten studies met the inclusion criteria (665 patients, mean age 29, mean follow-up 37 months) and underwent meta-analysis: three retrospective, four prospective cohort studies, and three randomised controlled trials. The meta-analysis demonstrated no significant differences between the Latarjet procedure and FBB techniques in recurrence rates of shoulder instability (RR 1.05; 95% CI 0.53–2.10; P = 0.87), PROMs (ASES, Rowe, SSV, WOSI, and VAS), or reoperation rate. No publication bias was detected (Egger’s P = 0.15). Regarding range of motion, no significant differences were observed in any of the parameters (abduction, external or internal rotation, and forward flexion). The limitations of our meta-analysis include high heterogeneity and serious risk of bias of studies.
Conclusion
Our results suggest that FBB procedures are viable and safe alternative treatment options to the Latarjet technique. Level of evidence III.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- King's College London, London, UK. aleksander.sulkowski@kcl.ac.uk.
- University College London, London, UK.
- Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
- West Hertfordshire Teaching Hospitals NHS Trust, Watford, UK.
- Chinese University of Hong Kong, Hong Kong, China.
- Royal Free London NHS Foundation Trust, London, UK.
Zitieren
APA
Sulkowski, A., Pathmaraj, B., Dhanak, D., Lu, V. Y., & Domos, P. (2025). Clinical outcomes and complications in Latarjet versus free bone block procedures for anterior shoulder instability: a meta-analysis of comparative studies. European Journal of Orthopaedic Surgery & Traumatology. https://doi.org/10.1007/s00590-025-04485-0
Vancouver
Sulkowski A, Pathmaraj B, Dhanak D, Lu VY, Domos P. Clinical outcomes and complications in Latarjet versus free bone block procedures for anterior shoulder instability: a meta-analysis of comparative studies. European Journal of Orthopaedic Surgery & Traumatology. 2025. doi:10.1007/s00590-025-04485-0
BibTeX
@article{Sulkowski2025,
author = {Sulkowski, Aleksander and Pathmaraj, Bavin and Dhanak, Dillan and Lu, Victor Yan-Zhe and Domos, Peter},
title = {Clinical outcomes and complications in Latarjet versus free bone block procedures for anterior shoulder instability: a meta-analysis of comparative studies},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2025},
doi = {10.1007/s00590-025-04485-0}
}
EUVIMED